Subject to, inter alia, market conditions, a SEK-denominated senior secured bond issue in an initial amount of MSEK 250 with a tenor of 3 years may follow. The net proceeds from the contemplated bond issue will be utilised to refinance the Company's outstanding bonds and other debt facilities, finance the previously announced acquisition of MRC Systems Ltd, and for general corporate purposes.

In conjunction with the contemplated bond issue and the acquisition of MRC Systems Ltd., Rikard Akhtarzand (CEO, board member and shareholder), Staffan Torstensson (chairman of the board and shareholder), Per Åhlgren (shareholder) and Magnus Vahlquist (shareholder) have expressed their intention to during the period 25 January to 8 February 2021 exercise their right to subscribe for shares under the Company's warrant programme, which will result in aggregate gross proceeds to the Company of approximately MSEK 14 before transaction costs.

For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 18 November 2020 at 07:45 CET.
 

About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.